Supriya Lifescience Reports Strong FY26 Results, Recommends 50% Dividend

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Supriya Lifescience Reports Strong FY26 Results, Recommends 50% Dividend
Overview

Supriya Lifescience reported strong financial performance for FY26, with revenue increasing by 18.86% to ₹8,278.75 million and profit rising 11.26% to ₹2,091.20 million. The company also recommended a final dividend of Re. 1.00 per share, equivalent to 50% of its face value.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Supriya Lifescience Ltd. Reports Strong Fiscal Year 2026 Performance

Supriya Lifescience Ltd. has announced its financial results for the fiscal year ending March 31, 2026. The company reported total revenue of ₹8,278.75 million, marking an 18.86% increase compared to the previous year. Net profit for the fiscal year stood at ₹2,091.20 million, representing an 11.26% rise.

In addition to its financial achievements, the company's board has recommended a final dividend of Re. 1.00 per equity share, which amounts to 50% of the face value of the share. This proposed dividend reflects the company's commitment to enhancing shareholder value.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.